April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Complement Factor H In Choroidal Neovascularization And Acute Injury
Author Affiliations & Notes
  • Kaiyan Zhang
    Ophthalmology, UT Southwestern Medical Center at Dallas, Dallas, Texas
  • Bogale Aredo
    Ophthalmology, UT Southwestern Medical Center at Dallas, Dallas, Texas
  • Cynthia Wang
    Ophthalmology, UT Southwestern Medical Center at Dallas, Dallas, Texas
  • Hua Lu
    Ophthalmology, UT Southwestern Medical Center at Dallas, Dallas, Texas
  • Shusheng Wang
    Ophthalmology, UT Southwestern Medical Center at Dallas, Dallas, Texas
  • Rafael Ufret-Vincenty
    Ophthalmology, UT Southwestern Medical Center at Dallas, Dallas, Texas
  • Footnotes
    Commercial Relationships  Kaiyan Zhang, None; Bogale Aredo, None; Cynthia Wang, None; Hua Lu, None; Shusheng Wang, None; Rafael Ufret-Vincenty, None
  • Footnotes
    Support  NIH Grant EY020799. Unrestricted grant from Research to Prevent Blindness, Inc. to the dDepartment of Ophthalmology, UT Southwestern Medical Center.
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 977. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Kaiyan Zhang, Bogale Aredo, Cynthia Wang, Hua Lu, Shusheng Wang, Rafael Ufret-Vincenty; Complement Factor H In Choroidal Neovascularization And Acute Injury. Invest. Ophthalmol. Vis. Sci. 2011;52(14):977.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Purpose: Complement factor H is an important regulator of complement activation. Some single nucleotide polymorphisms in complement factor H are associated with an increased risk of AMD. It is thought that this may be due to a chronic increase in complement activation in the subretinal space. However, we would like to explore the role of Cfh in the more acute scenarios of choroidal neovascularization and light injury.

Methods: : Methods: We are studying the development of choroidal neovascularization (CNV) using the laser injury model in 3-6 m old Cfh transgenic mice compared to age-matched B6 mice. ICAM-stained choroidal flat mounts were used to measure the size of CNV membranes. As a separate model of acute injury, we are also comparing the effect of intense/acute light injury in these two groups of mice. Fundus photography, light microscopy, RPE/choroid flat mounts and immunohistochemistry analysis were used to compare the response to light injury in Cfh transgenic vs. B6 mice.

Results: : Results: The results of two separate laser injury experiments comparing CNV size in Cfh transgenic mice to B6 mice will be presented. We will also present the results of two separate light injury experiments comparing the fundus appearance, light microscopy changes, the number and type of macrophages, and the deposition of C3d in the retina/RPE/Bruch’s membrane/choroid of the Cfh transgenic vs. B6 mice.

Conclusions: : Conclusions: The neovascular stage of AMD likely involves pathologic events that are different from those in the early stages of the disease. Although some epidemiologic studies suggest that Cfh may also be involved in this process, the data is not as compelling or consistent. We present data in our mouse model that may shed some light regarding the relevance of complement activation and complement factor H in acute injury and acute choroidal neovascularization.

Keywords: age-related macular degeneration • choroid: neovascularization • microglia 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×